EXO Biologics is a biotech company developing biopharmaceuticals using extracellular vesicles.
EXO Biologics has raised $16.0M in total funding. The most recent round was Series A. The last funding was announced in April 2024.
EXO Biologics's investors include Meusinvest (Noshaq), Walloon.
EXO Biologics is headquartered in Liège, Belgium.
EXO Biologics is a biotech company developing biopharmaceuticals using extracellular vesicles.
EXO Biologics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EXO Biologics — Funding & Investors." VCBacked, April 24, 2024, https://www.vcbacked.co/company/exo-biologics. Accessed August 14, 2026.
VCBacked. (2024). EXO Biologics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/exo-biologics
{{cite web |title=EXO Biologics — Funding & Investors |url=https://www.vcbacked.co/company/exo-biologics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated